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“coverage gap days” was conducted for the study population. A
MPR of ≥0.8 was considered adherent. RESULTS: Of approxi-
mately 13,000 standard Medicare Part D patients, 189 had
claims for both a statin and a PO anti-diabetic during January
2006, and subsequently experienced the coverage gap. The
number of patients reaching the “doughnut hole” or coverage
gap in a given month ranged from 4 to 41, starting in April. The
average “pre-gap” and “gap” periods were 242 days and 123
days, respectively. The average MPR for PO anti-diabetics during
the “pre-gap” period was 24% higher than during the “gap”
(0.92 vs. 0.70). For the statins, there was an 18% decrease in
the average MPR between the “pre-gap” period and the “gap”
period (0.87 vs. 0.72). CONCLUSION: The overall medication
compliance (i.e. MPR) of statins and oral anti-diabetics
decreased during the 2006 Medicare Part D beneﬁt coverage gap
period. On average, patients became more non-adherent with
their statin and oral anti-diabetic therapies during the “gap”
period.
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OBJECTIVES: This study sought to evaluate the impact of con-
verting to insulin administration with an insulin aspart analog
pen from vial/syringe on medication adherence among type 2
diabetes patients. METHODS: A pre-post conversion approach
was adopted using an integrated medical and pharmacy claims
database from >50 managed care health plans in the United
States. Adults diagnosed with type 2 diabetes who converted to
insulin aspart pen therapy (NovoLog® FlexPen®) [index event]
from either human or analog insulin vials between July 2001 and
December 2002 with no prior use of FlexPen® for six months
were identiﬁed. Medication adherence in the pre and post-index
periods was measured using medication possession ratio (MPR).
Paired t-test was performed to test the statistical differences in
adherence rates. RESULTS: Data from 670 patients (prior analog
insulin vial/syringe users: 328; human insulin vial/syringe users:
342) newly treated with FlexPen® were analyzed. Mean patient
age was 45.7 years (SD: 13.8 years) and 50.8% were male. Upon
initiating FlexPen®, MPR was signiﬁcantly improved to 70%
(SD: 32%) in comparison to 65% (SD: 29%), p < 0.01, prior to
FlexPen® use. Previous human vial/syringe users [human pre-
mix users: 76% vs. 82%; p = 0.01, and NPH users: 66% vs.
70%; p = 0.02] showed the highest improvement in adherence
in the post-index period of 5 percentage points (71% vs. 76%;
p = 0.01), as compared to 4 percentage points (61% vs. 65%; p
= 0.01) among prior analog vial/syringe users [glargine users:
63% vs. 67%; p = 0.03, and analog pre-mix users: 59% vs. 63%;
p = 0.03]. CONCLUSION: Medication adherence to insulin
therapy based on MPR was signiﬁcantly improved following the
initiation of insulin aspart analog pen in type 2 diabetes patients.
Further analyses should evaluate the impact of improved adher-
ence on clinical health outcomes and associated costs.
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OBJECTIVES: To examine the relationship between eating
healthy foods and exercising regularly on physical health (PH),
mental health (MH), and perceived health status (PHS) among
type II diabetics. METHODS: The 2005 Center for Disease
Control and Prevention’s Behavioral Risk Factor Surveillance
System, a cross-sectional survey, was utilized. Respondents were
considered type II diabetics if diagnosis occurred minimally at
age 30. Eating healthy foods was deﬁned as eating at least 5 serv-
ings of fruits and vegetables daily. Exercising regularly was
deﬁned as meeting the recommendations for moderate and/or
vigorous exercise. Due to impact on quality of life we included
demographics, socioeconomic status, comorbidities, diabetic
complications, and insulin use as covariates. Poisson regressions
were used to compare the monthly number of PH or MH days
associated with eating healthy foods and exercising regularly.
Logistic regression determined the association between PHS
(good versus poor) and eating healthy foods or exercising regu-
larly. RESULTS: Among 21,590 type II diabetics identiﬁed, the
majority were Caucasian, older, urban, hypertensive, and did not
meet recommendations. Eating 3–4 servings of fruits and veg-
etables was associated with 0.1 (4.4%) and 2.9 (17.6%) more
days in which PH and MH was good compared to 5 servings (p
= 0.0113 and p < 0.0001). Consuming 1–2 servings of fruit and
vegetables daily was associated with lower PHS (p < 0.0001).
No exercise was associated with 5.8 (34.0%) fewer days of good
PH (p < 0.0001), 3.6 (21.9%) fewer days of good MH (p <
0.0001), and 8% lower odds of good PHS (p < 0.0001) com-
pared to people who exercise regularly. Annual household
income <$15,000 consistently was associated with poorer PH 
(p < 0.0001), MH, (p < 0.0001), and PHS (p < 0.0001). CON-
CLUSION: Glycemic effects from fruits and vegetables may con-
tribute to more PH and MH days for 3–4 daily servings
compared to 5. Causation cannot be inferred from these results
due to its cross-sectional and observational nature.
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OBJECTIVES: The risk of developing cardiovascular and other
life threatening diseases is strongly linked to increased body
weight. This is particularly relevant to people with type 2 dia-
betes (T2D) in whom over 80% are overweight. Limited data
exist on the impact on Health Related Quality of Life (HRQOL)
of Body Mass Index (BMI) for people with type 2 diabetes. The
aim of this study was to characterize the impact of BMI on
HRQOL for people with and without T2D in England.
METHODS: Data from the Health Survey for England 2003
(HSE03) was evaluated. HSE03 consisted of a stratiﬁed random
sample designed to provide data about the general population
living in private households in England. Observations for 13,233
non-diabetic patients and 461 patients with T2D were included.
HRQOL was measured using the EQ-5D. Overall HRQOL dif-
ferences were investigated using t-tests. Analyses of variance
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(ANOVA) were used to investigate relations between EQ-5D
scores and categories of BMI (underweight (<18.5), normal
(18.5–<25), overweight (25–<30), obese (30–<40) and extremely
obese (>40). RESULTS: The overall HRQOL was signiﬁcantly
lower for people with T2D compared to non-diabetic patients,
with EQ-5D scores of 0.795 versus 0.867, respectively (p < 0.01).
An ANOVA showed that the non-diabetic obese subgroup (BMI
>−30) had a signiﬁcant reduced HRQOL compared to others 
(p < 0.05). The HRQOL for people with T2D was signiﬁcantly
(p < 0.05) lower for the morbidly obese (BMI >40) compared to
people in the normal weight band (BMI of 18.5–<25). The
HRQOL was lower for people with T2D across all BMI cate-
gories compared to non-diabetics. CONCLUSION: These ﬁnd-
ings suggest that obesity in the general adult population in
England has a signiﬁcant impact on HRQOL. The impact of
obesity on HRQOL is particularly evident in people with T2D
who are further burdened by the impact of their disease.
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OBJECTIVES: To (1) determine the prevalence of depression in
primary care patients with type 2 diabetes mellitus (T2DM) and
(2) compare HRQoL in diabetic patients based on the severity
of depressive symptoms. METHODS: Primary care patients with
T2DM were recruited during their scheduled clinic appoint-
ments. Self-reported data on demographic characteristics were
collected via a survey. Data on Hemoglobin A1C values and
comorbid conditions were collected from patient charts. The
Zung self-rating depression scale was used to measure depressive
symptoms and the SF-8 was used to measure HRQoL. Analysis
of variance (ANOVA) was used to compare HRQoL summary
scores and domain scores for general health (GH), physical func-
tioning (PF), role physical (RP), bodily pain (BP), vitality (VI),
social functioning (SF), mental health (MH) and role emotional
(RE) in diabetic patients based on the severity of symptoms.
RESULTS: A total of 217 surveys were collected with a usable
response rate of 93%. The mean age of the overall sample was
57.3 years (SD = 11.9), 62.2% were female and 61% were His-
panic. The Zung self-rating depression scale indicated that
72.1% of patients met criteria for depression. Scores for the
domains of GH, PF, RP, BP, VI, SF, MH and RE decreased sig-
niﬁcantly (p < 0.001) as the severity of depressive symptoms
increased. Similarly, ANOVA results showed that summary
scores for PCS-8 (F = 24.16, p < 0.001) and MCS-8 (F = 40.00,
p < 0.001) decreased signiﬁcantly as depressive symptom sever-
ity increased. Post-hoc analyses revealed signiﬁcant differences
between groups. CONCLUSION: Patients with T2DM were
found to have a high prevalence of depressive symptoms, includ-
ing symptoms of severe depression. Mental as well as physical
HRQoL decreased signiﬁcantly as the severity of depressive
symptoms increased. Detection and treatment of depression 
may help to improve HRQoL in patients with type 2 diabetes
mellitus.
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OBJECTIVES: Understanding the impact of diabetes on quality
of life may provide impetus for education and prevention. This
study assessed differences in health-related quality of life
(HRQoL) across respondents with type 2 diabetes (T2D) and
groups with varying levels of cardiometabolic risk for develop-
ing T2D. METHODS: The Study to Help Improve Early evalu-
ation and management of risk factors leading to Diabetes
(SHIELD) is a US longitudinal study of individuals with or at
risk for T2D. Respondents without diabetes but with 3–5 car-
diometabolic risk factors for T2D (abdominal obesity, BMI ≥28
kg/m2, reported diagnosis of cholesterol problems, hypertension
or coronary heart disease or stroke) were classiﬁed as high risk
and respondents with ≤2 of these risk factors as low risk.
HRQoL was measured by the EQ-5D visual analog scale (VAS)
and index utility score. Baseline mean VAS and utility scores
(using US population values) were compared across the three
respondent groups using analysis of variance with post-hoc
testing. RESULTS: Mean VAS scores for T2D and high-risk
respondents (66.8 and 70.4, respectively) were signiﬁcantly
reduced compared with low-risk respondents (79.6, p < 0.001).
Mean index utility scores for T2D and high-risk groups (0.78
and 0.79, respectively) were substantially lower than those for
low-risk group (0.87, p < 0.001). Additionally, the mean VAS
and utility scores for T2D respondents were signiﬁcantly lower
than those of high-risk respondents (p < 0.001). Greater decre-
ments were reported in all domains by T2D and high-risk
respondents compared with low-risk respondents, with the
largest difference in decreased mobility (47.9%, 43.4%, 17.1%,
respectively). CONCLUSION: SHIELD results demonstrated
that respondents with or at higher risk for T2D report decreased
overall HRQoL, resulting from lower scores in every domain,
compared with those at low risk. Even before T2D diagnosis,
reducing cardiometabolic risk levels may lead to signiﬁcant
improvement in HRQoL.
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OBJECTIVES: The 25-Item National Eye Institute Visual Func-
tion Questionnaire (VFQ-25) was designed to assess the inﬂu-
ence of visual impairment on health-related quality of life
(HRQL). The instrument has been developed and validated in
samples of patients with various vision problems, but it has not
previously been validated speciﬁcally for use in patients with dia-
betic retinopathy (DR). The purpose of this study was to assess
the reliability and validity of the VFQ-25 in patients with DR.
METHODS: Data were from a multicenter study on vision loss
in patients with type 1 or type 2 diabetes and moderate to severe
nonproliferative DR. Visual acuity was deﬁned at each time point
as each individual’s best corrected vision as determined by the
ETDRS visual acuity chart score. Patients completed the VFQ-
